Autoimmune c1 inhibitor deficiency and angioedema

Dermatology

Volumn 195, Issue 2, 1997, Pages 169-172

  Valsecchi, R ^a   Reseghetti, A ^a   Pansera, B ^a   Di Landro, A ^a  

^a Department of Dermatology   (Italy)

Author keywords

Acquired angioneurotic edema; Autoantibody; Complement

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR; TRANEXAMIC ACID;

ABDOMINAL DISCOMFORT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; AUTOIMMUNITY; CASE REPORT; COMPLEMENT DEFICIENCY; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL;

EID: 0030835935     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245725     Document Type: Article

References (23)

1. Johnson AM, Alpcr CA. Rosen FS. Craig JM: Clinhibitor: Evidence for decreased hepatic synthesis in angioneurotic edema. Science 1971:173:553-554.
2. Davis AF.: Cl inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988: 6:595-628.
3. Frank MM: The Cl esterase inhibitor and hereditary angioedema. J Clin Immunol 1982: 2:65-68.
4. Kerr MA. Yeung-Laiwah AC: Cl-inhibitordeficiency and angioedema; in Whaley K (ed): Complement in Health and Disease. Lancaster. MBT Press. 1987. p 57.
5. Shoemaker LR, Schurman SJ, Donaldson VH. Davis AF.: Hereditary angioneurotic edema: Characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 1994:95:22-28.
6. Caldwell JR. Ruddy S. Schur PH. Austen KF: Acquired Cl inhibitor deficiency in lymphosarcoma. Immunol Immunopathol 1972:1: 39-52.
7. Gelfand JA. Boss GR. Conley CL. Reinhart R. Frank MM: Acquired Cl esterase inhibitor deficiency and angioedema: A review. Medicine 1979:58:321-328.
8. Sheffer AL. Austen KF. Rosen FS, Fearon DT: Acquired deficiency of the inhibitor of the first component of complement: Report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 1985:75: 640-646.
9. Jackson J, Sim RB, Feighery C: An IgG auto-antibody which inactives Cl-inhibitor. Nature 1986:323:722-724.
10. Alsenz J. Bork K. Loos M: Autoantibody-mediated acquired deficiency of Cl-inhibitor. N Engl J Med 1987:316:1360-1366.
11. Spath PJ. Wiithrich B. Matter L. Loos M. Albenz L: Acquired angioedema and CI-inhibitor autoantibodies. Arch Intern Med 1989: 149:1213-1216.
12. Spath PJ. Wiithrich B: Angioedema: A review of the acquired, allergic or noil-allergic, and hereditary forms. Rec Prog Med 1990:81: 513-518.
13. Ollavri ZN. Wong HCC. Atkinson JP. Tung KSK: Cl inhibitor deficiency: Molecular and immunologic basis of hereditary and acquired angioedema. Lab Invest 1991:65:381-388.
14. Cicardi M. Bisiani G. Cugno M. Spath P. Agos-toni A: Autoimmune Cl inhibitor deficiency: Report of eight patients. Am J Med 1993:95: 169-175.
15. Melamed J. Alper CA. Cicardi M. Rosen FS: The metabolism of Cl-inhibitor and Clq in patients w ith acquired CI -inhibitor deficiency. J Allergy Clin Immunol 1986:77:322-326.
16. Agostoni A. Cicardi M: Hereditary and acquired Cl-inhibitor deficiency: Biological and clinical characteristics in 325 patients. Medicine 1992:71:206-215.
17. Jackson J. Sim RB. Whaley K. Feighery C: Autoantibody facilitated cleavage of Cl-inhibitor in autoimmune angioedema. J Clin Invest 1989:83:698-707.
18. Mandle R. Baron C. Roux E. Sundel R. Geefand J. Aulak K. Davis AE. Rosen FS. Bing DH: Acquired Cl inhibitor deficiency as a result of an autoantibody to the reactive center region of Cl inhibitor. J Immunol 1994:152: 4680-4685.
19. Donaldson VH. Wagner CJ. Davis AEH: An autoantibody to CI -inhibitor recognizes the reactive center of the inhibitor. J Lab Clin Med 1996:127:229-232.
20. Donaldson VH. Bernstein DI. Wagner CJ. Mitchell BH. Scinto J. Bernstein IL: Angioneurotic edema with acquired Cl-inhibitor deficiency and autoantibody to Cl inhibitor: Response to plasmapheresis and cytotoxic therapy. J Lab Clin Med 1992:119:397-406.
21. Spath PJ. Wiithrich B. Butler R: Cl-inhibitor functional activities in hereditary angioedema plasma of patients under therapy with attenuated androgens. Dermatologica 1984:169: 301-304.
22. Verstrate M: Clinical application of inhibitors of fibrinolysis. Drugs 1985:29:236-261.
23. Cugno M. Cicardi M. Agostoni A: Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol 1994:93:870-876.